Hans Klein
Impact in
- Biological Psychiatry top 0.2%
- Tryptophan and brain disorders
- Behavioral Neuroscience top 0.5%
- Stress Responses and Cortisol
Papers in
-
- Tryptophan and brain disorders 22
- Epidemiology 13
- Herpesvirus Infections and Treatments 6
- Cytomegalovirus and herpesvirus research 5
- Co-authors
- Janine Doorduin (15 shared papers)Erik F. J. de Vries (15 shared papers)Rudi Dierckx (16 shared papers)Bruno Lima Giacobbo (1 shared paper)Elke Bromberg (1 shared paper)Jan Cees de Groot (2 shared papers)Antoon T. M. Willemsen (2 shared papers)Hemmo A. Drexhage (2 shared papers)
- Journals
- Frontiers in Psychiatry (3 papers)Molecular Neurobiology (3 papers)PLoS ONE (3 papers)NeuroImage (2 papers)Current Pharmaceutical Design (2 papers)
- Partner nations
- NetherlandsSouth AfricaBrazil
In The Last Decade
Hans Klein
59 papers receiving 2.6k citations
Hans Klein's Hit Papers
Peers
Comparison fields: 5 of 133
- Biological Psychiatry 1.1k
- Behavioral Neuroscience 588
- Neurology 762
- Developmental Neuroscience 149
- Psychiatry and Mental health 484
Countries citing papers authored by Hans Klein
This map shows the geographic impact of Hans Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Klein more than expected).
Fields of papers citing papers by Hans Klein
This network shows the impact of papers produced by Hans Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Klein. The network helps show where Hans Klein may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation Hit paper breakdown → | 2018 | 559 |
| 2 | 2009 | 446 | |
| 3 | 2012 | 289 | |
| 4 | 2017 | 203 | |
| 5 | 2014 | 164 | |
| 6 | 2009 | 101 | |
| 7 | 2016 | 83 | |
| 8 | 1988 | 80 | |
| 9 | 2015 | 73 | |
| 10 | 2015 | 61 | |
| 11 | 2018 | 44 | |
| 12 | 2012 | 43 | |
| 13 | 2015 | 41 | |
| 14 | 2014 | 34 | |
| 15 | 2015 | 28 | |
| 16 | 1985 | 28 | |
| 17 | 2011 | 25 | |
| 18 | 2018 | 24 | |
| 19 | 2017 | 21 | |
| 20 | 2009 | 21 |
About Hans Klein
Hans Klein is a scholar working on Biological Psychiatry, Epidemiology, Psychiatry and Mental health, Infectious Diseases and Behavioral Neuroscience, having authored 61 papers that have together received 2.7k indexed citations. Recurring topics across this work include Tryptophan and brain disorders (22 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Stress Responses and Cortisol (10 papers), Herpesvirus Infections and Treatments (6 papers), Schizophrenia research and treatment (5 papers), Cytomegalovirus and herpesvirus research (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Adenosine and Purinergic Signaling (4 papers). The work is most often cited by research in Biological Psychiatry (1.1k citations), Behavioral Neuroscience (588 citations), Neurology (762 citations), Developmental Neuroscience (149 citations) and Psychiatry and Mental health (484 citations). Hans Klein has collaborated with scholars based in Netherlands, South Africa and Brazil. Frequent co-authors include Janine Doorduin, Erik F. J. de Vries, Rudi Dierckx, Bruno Lima Giacobbo, Elke Bromberg, Jan Cees de Groot, Antoon T. M. Willemsen, Hemmo A. Drexhage, Robert A. Schoevers and Johann Steiner. Their work appears in journals such as Frontiers in Psychiatry, Molecular Neurobiology, PLoS ONE, NeuroImage and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.